← Back to search
BATAVIA BIOSCIENCES INC.
WOBURN, MA, 01801
Unclaimed
Subcontracting experience
17 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Health and Human Services | TO52: COLLECTION OF RVSVΔG-MARV-GP AND RVSVΔG-SUDV-GP VIRUS SEEDS A13158 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: NY Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN View parent award on USAspending | — | $44,568 | Mar 20, 2026 | — – — |
| Subcontractor | Department of Health and Human Services | TO 44: RVSVΔG-MARV-GP & RVSVΔG-SUDV-GP: GMP DILUENT FILL AND STABILITY STUDIES A12305 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: NY Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN View parent award on USAspending | — | $113,027 | Oct 17, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | RVSVΔG-MARV-GP, RVSVΔG-SUDV-GP, AND DILUENT: RE-LABELING AND SHIPMENT TO DDL A12866 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: NY Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN View parent award on USAspending | — | $36,813 | Aug 6, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | TASK ORDER N° 30 PROCESS IMPROVEMENT VSV-MARBURG A11281 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: NY Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN View parent award on USAspending | — | $257,929 | Mar 27, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | TO 44: RVSV΀?G-MARV-GP & RVSV΀?G-SUDV-GP: GMP DILUENT FILL AND STABILITY STUDIES A12305 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: NY Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN View parent award on USAspending | — | $431,818 | Oct 7, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | TASK ORDER N° 40 ANALYTICAL ACTIVITIES FOR RVSV΀?G-MARV-GP A11893 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: NY Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN View parent award on USAspending | — | $93,330 | Mar 14, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | TASK ORDER N° 41 CONFIRMATION OF THE FORMULATION BUFFER FOR RVSV΀?G-SUDV-GP A11879 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: NY Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN View parent award on USAspending | — | $1,109,771 | Mar 7, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | TASK ORDER N° 30 PROCESS IMPROVEMENT VSV-MARBURG A11281 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: NY Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN View parent award on USAspending | — | $1,937,737 | Feb 22, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | TASK ORDER N° 30 PROCESS IMPROVEMENT VSV-MARBURG A11281 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: NY Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN View parent award on USAspending | — | $652,921 | Jun 7, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | TASK ORDER N° 014 DEVELOPMENT OF A SCALABLE FILTRATION PROCESS FOR VSV΀?G-SUDV-GP A10500 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: NY Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN View parent award on USAspending | — | $46,483 | May 2, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | MANUFACTURING OF A VSV΀?G MARV WORKING VIRUS SEED AND STORAGE OF MVS AND WVS A11007 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: NY Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN View parent award on USAspending | — | $575,354 | Jan 24, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | TASK ORDER N° 22 CGMP MANUFACTURING AT 10M2 OF VSV΀?G-EBOLA SUDAN €€Œ RUN 2 A10854 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: NY Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN View parent award on USAspending | — | $2,124,229 | Nov 21, 2022 | — – — |
| Subcontractor | Department of Defense | TASK ORDER N° 016 MSV AND ENGINEERING RUN OF RVSV-SARS COV-2 DELTA CONSTRUCT A10268 Parent award context Parent award agency: Department of Defense · Defense Threat Reduction Agency Parent award NAICS: 541715 Parent award performance state: NY Parent award description: ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM View parent award on USAspending | — | $261,340 | Jun 8, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | TASK ORDER N° 014 DEVELOPMENT OF A SCALABLE FILTRATION PROCESS FOR VSV΀?G-SUDV-GP A10500 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: NY Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN View parent award on USAspending | — | $133,702 | May 18, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | TASK ORDER N° 014 DEVELOPMENT OF A SCALABLE FILTRATION PROCESS FOR VSV΀?G-SUDV-GP A10500 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: NY Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN View parent award on USAspending | — | $755,086 | Mar 31, 2022 | — – — |
| Subcontractor | Department of Defense | TASK ORDER N° 016 MSV AND ENGINEERING RUN OF RVSV-SARS COV-2 DELTA CONSTRUCT A10268 Parent award context Parent award agency: Department of Defense · Defense Threat Reduction Agency Parent award NAICS: 541715 Parent award performance state: NY Parent award description: ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM View parent award on USAspending | — | $2,607,552 | Feb 10, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | TASK ORDER N° 17 CGMP MANUFACTURING OF VSV΀?G-EBOLA SUDAN A10281 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: NY Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN View parent award on USAspending | — | $5,516,412 | Jan 26, 2022 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.